The diagnostic yield of genetic and metabolic investigations in syndromic and nonsyndromic patients with autism spectrum disorder, global developmental delay, or intellectual disability from a dedicated neurodevelopmental disorders genetics clinic
Julianne K. Postma(Agricultural Research Institute of Ontario), Melissa T. Carter(University of Ottawa), Danielle K. Bourque(Newborn Screening Ontario), Stan Kutcher(Izaak Walton Killam Health Centre), Richard Webster(Children's Hospital of Eastern Ontario), Mary‐Ann Harrison(Agricultural Research Institute of Ontario), Andrea C. Yu(Newborn Screening Ontario), M. Cloutier(Agricultural Research Institute of Ontario)
Cited by 8
Related Papers
Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
|Journal of the American Academy of Child & Adolescent Psychiatry|2001|648
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
Whole-genome sequencing of quartet families with autism spectrum disorder
|Nature Medicine|2015|540
Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing
|The American Journal of Human Genetics|2013|496